Additionally, DDR2 signaling may mediate collagen’s impact on immunotherapy response, as joint administration of anti-PD-1 antibodies and a DDR2 inhibitor boosts CD8+ T-cell infiltration and decreases tumor burden in multiple mouse cancer models [134]. This evidence concerns the gene CD8A and neoplasm.